ONCORESPONSE

OncoResponse Inc., an immuno-oncology company located in Houston, Texas, has partnered with MD Anderson Cancer Center (MDACC) to deploy a unique and transformational approach to cancer therapeutic monoclonal antibody and target discovery. The company licensed the I-STAR™ platform, developed and validated by Theraclone Sciences of Seattle, to interrogate the human memory B-cell repertoire of cancer patients who are considered “Elite Responders” to immunotherapy; as such, their own adaptive ... immune system responded to immunotherapy stimulation in a way that achieved curative or durable responses. From these Elite Responders, OncoResponse is leveraging the human immune system to identify fully human monoclonal antibodies and discover novel targets that will lead to the development of fully human antibody derived therapeutics for the treatment of cancer.

#SimilarOrganizations #People #Financial #Website #More

ONCORESPONSE

Social Links:

Linkedin

Industry:

Biopharma Biotechnology Health Care Therapeutics

Founded:

2015-01-01

Address:

Seattle, Washington, United States

Country:

United States

Website Url:

http://www.oncoresponseinc.com

Total Employee:

11+

Status:

Active

Contact:

206-805-1600

Email Addresses:

[email protected]

Total Funding:

103.1 M USD

Technology used in webpage:

SPF Domain Not Resolving Euro Microsoft Exchange Online Office 365 Mail GoDaddy DNS GoDaddy Zoom Video Conferencing Zoom KnowBe4

Similar Organizations

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

excision-biotherapeutics-logo

Excision BioTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

Current Advisors List

not_available_image

Patrick Hojlo Board Member @ OncoResponse
Board_member
2021-03-01

daguan-wang_image

Daguan Wang Board Member @ OncoResponse
Board_member
2021-03-01

not_available_image

Ted Koutouzis Board Member @ OncoResponse
Board_member
2021-03-01

roberto-de-ponti_image

Roberto De Ponti Board Member @ OncoResponse
Board_member

andrew-perlman_image

Andrew Perlman Board Member @ OncoResponse
Board_member

john-mckearn_image

John McKearn Board Member @ OncoResponse
Board_member

michael-outwin_image

Michael Outwin Board Observer @ OncoResponse
Board_member
2016-01-01

steven-gillis_image

Steven Gillis Board Member @ OncoResponse
Board_member

Current Employees Featured

bob-lechleider_image

Bob Lechleider
Bob Lechleider Chief Medical Officer @ OncoResponse
Chief Medical Officer
2020-01-01

clifford-j-stocks_image

Clifford J. Stocks
Clifford J. Stocks CEO @ OncoResponse
CEO
2015-10-01

kamal-d-puri_image

Kamal D. Puri
Kamal D. Puri Chief Scientific Officer @ OncoResponse
Chief Scientific Officer
2018-01-01

Founder

clifford-j-stocks_image

Clifford J. Stocks

Acquisitions List

Date	Company	Article	Price
2017-11-07	Paganini Biopharma	Paganini Biopharma acquired by OncoResponse	N/A

Investors List

bering-capital_image

Bering Capital

Bering Capital investment in Series C - OncoResponse

arch-venture-partners_image

ARCH Venture Partners

ARCH Venture Partners investment in Series C - OncoResponse

rivervest_image

RiverVest

RiverVest investment in Series C - OncoResponse

qatar-investment-authority_image

Qatar Investment Authority

Qatar Investment Authority investment in Series C - OncoResponse

canaan-partners_image

Canaan Partners

Canaan Partners investment in Series C - OncoResponse

redmile-group_image

Redmile Group

Redmile Group investment in Series C - OncoResponse

yonjin-venture_image

Yonjin Venture

Yonjin Venture investment in Series C - OncoResponse

helsinn-investment-fund_image

3B Future Health Fund

3B Future Health Fund investment in Series C - OncoResponse

magnetar-capital_image

Magnetar Capital

Magnetar Capital investment in Series C - OncoResponse

qatar-investment-authority_image

Qatar Investment Authority

Qatar Investment Authority investment in Series B - OncoResponse

Official Site Inspections

http://www.oncoresponseinc.com

Host Informations
Whois Informations

Loading ...

More informations about "OncoResponse" on Search Engine